Cypros Pharmaceutical Corp.
12Patents
0Active
12Granted
31Portfolio score
Filing activity: Nov 4, 1991 → Apr 15, 1998
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5677288A | Use of aminoglycosides to protect against excitotoxic neuron damage | Human Necessities | 27 | Expired |
| US5206264A | Use of disulfiram to prevent cardiovascular damage | Human Necessities | 19 | Expired |
| US5373021A | Use of disulfiram for Neuronal Protection | Human Necessities | 16 | Expired |
| US5944020A | Use of fructose-1 6-diphosphate as an inotrope drug after cardiopulmonary bypass surgery | Human Necessities | 14 | Expired |
| US5731291A | Partially lyophilized fructose-1,6-diphosphate (FDP) for injection into humans | Chemistry; Metallurgy | 7 | Expired |
| US6011017A | Method of reducing pulmonary hypertension and atrial fibrillation after surgery using cardiopulmonary bypass | Electricity | 6 | Expired |
| US5587397A | Reduction of elevated blood lactate using twice-daily dichloroacetate | Human Necessities | 6 | Expired |
| US6063819A | Neuroprotective poly-guanidino compounds which block presynaptic N and P/Q calcium channels | Human Necessities | 5 | Expired |
| US6076528A | Injection of fructose-1,6-diphosphate (FDP) prior to coronary artery bypass grafting surgery | Human Necessities | 5 | Expired |
| US5910127A | On-site emergency treatment of injured or unconscious patients, using fructose-1,6-diphosphate (FDP) | Chemistry; Metallurgy | 2 | Expired |
| US6074658A | Treatment of sickle cell anemia crises with fructose-1, 6-diphosphate as an analgesic drug | Human Necessities | 1 | Expired |
| US5491146A | Hydroxylated erythro-hydroxynonyladenines and related analogs | Chemistry; Metallurgy | 1 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.